UK markets closed

Novo Nordisk A/S (0QIU.IL)

IOB - IOB Delayed price. Currency in DKK
Add to watchlist
911.00-2.75 (-0.30%)
At close: 05:55PM BST
Full screen
Previous close913.75
Open911.00
Bid872.90 x 0
Ask929.30 x 0
Day's range880.00 - 918.30
52-week range86.66 - 932.00
Volume241,331
Avg. volume1,004,356
Market cap3.825T
Beta (5Y monthly)0.21
PE ratio (TTM)61.31
EPS (TTM)14.86
Earnings date07 Aug 2024
Forward dividend & yield7.08 (1.04%)
Ex-dividend date18 Aug 2023
1y target estN/A
  • Investor's Business Daily

    Microsoft Leads Five Stocks Near Buy Points As Market Flashes Green

    Microsoft is near a buy point with the market rally flashing green. It's one of five stocks to watch.

  • Zacks

    Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates

    Bayer (BAYRY) releases Q1 results. J&J (JNJ) set to acquire private biotech, Proteologix, which will add atopic dermatitis candidates.

  • Globe Newswire

    Novo Nordisk A/S - share repurchase programme

    Bagsværd, Denmark, 17 May 2024 – On 6 May 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period beginning 6 February 2024. Under the programme initiate